First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer

This study is a first in human, two-stage single arm non-comparative study of safety and performance. The aim of the study is to asses the safety and the clinical performance of a new device : the MATTISSE tissu engineering chamber.

Trial Details

NCT ID
NCT05460780
Phase
NA
Sponsor
Quanta Medical
Status
RECRUITING
Cancer Type
Inflammatory Breast Cancer Breast Cancer
Interventions
  • MATTISSE TEC
Locations (sample)
  • Strasbourg, France, France|48.58392,7.74553
  • Lille, Nord, France|50.63391,3.05512
  • Tbilisi, Georgia|41.69143,44.83412

Key Eligibility Criteria

  • Criteria related to pathology:
  • Female patient over 18 Years old
  • Patient who required autologous breast reconstruction:
  • Immediate unilateral reconstruction after total mastectomy for early-stage breast cancer

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Inflammatory Breast Cancer Breast Cancer Trials on Trialify →